Accuray Incorporated (NASDAQ: ARAY) recently announced that the first CyberKnife System in Manhattan is now treating patients at Winthrop University Hospital's NYCyberKnife Center. Winthrop's decision to install the latest generation CyberKnife M6 System reinforces its growing reputation as a dedicated radiosurgery device that delivers extremely precise full-body treatments while maximizing patients' quality of life during and after treatment.
The CyberKnife M6 System's true robotic mobility enables it to deliver radiation beams from a wide range of angles around the body, precisely targeting tumors while avoiding healthy tissue. It can be used to treat tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas and kidney. The treatment – which delivers high doses of radiation to tumors with extreme accuracy – may offer hope to patients who have inoperable or surgically complex tumors, or who may prefer a clinically effective, non-surgical option.
The CyberKnife System's ability to automatically stay on target despite patient and tumor motion is what truly differentiates it from other forms of radiation therapy systems. It automatically follows the tumor throughout the treatment process, intelligently delivering radiation with sub-millimeter precision. This unique, dynamic motion compensation feature enables clinicians to precisely maximize dose, minimize side effects and maximize patient comfort.
Joshua H. Levine, president and chief executive officer of Accuray, said “The CyberKnife System is a transformative innovation, changing the face of cancer treatment and enabling clinicians to help their patients live longer, better lives. We're honored that Winthrop selected our system and want to congratulate the team as they expand their significant clinical expertise to treating patients in Manhattan with the CyberKnife System.”
Jonathan Haas, MD, chief, Division of Radiation Oncology at Winthrop-University Hospital, said “The Winthrop team is excited to be the first center in Manhattan to offer patients requiring radiation therapy the option to receive treatment with the CyberKnife System. We saw the considerable benefits the system has provided to our patients in Mineola, so when considering alternatives for our new location, it was an easy choice. We selected the CyberKnife M6 System because it includes the features and precision of the previous model, with the potential to provide faster treatment times and expand access to more patients.”
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
Via PR Newswire
Advertisement
Learn more about Electronic Products Magazine
